IMCR 8-K 2026-11-06

Immunocore Holdings plc (IMCR) 8-K dated 2026-11-06 — accession 0001671927-26-000034.

Immunocore Holdings plc (IMCR) is a biotechnology company listed on NASDAQ.

IMCR: Immunocore reports third quarter financial results and provides a busin…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IMCR revenue for 2025-12-31 was $400.0M. Net income was -$35.5M. Revenue was up 29.0% from 2024-12-31 to 2025-12-31. IMCR currently screens at market cap $1.45B.

Not investment advice. The IMCR SEC hub lists recent forms. The stock page is the research view.